MANDATO, Claudia
 Distribuzione geografica
Continente #
AS - Asia 5.328
NA - Nord America 4.720
EU - Europa 1.446
SA - Sud America 550
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 12.133
Nazione #
US - Stati Uniti d'America 4.615
HK - Hong Kong 2.909
SG - Singapore 1.159
CN - Cina 437
BR - Brasile 423
IT - Italia 390
VN - Vietnam 363
RU - Federazione Russa 245
UA - Ucraina 165
FR - Francia 126
DE - Germania 119
IE - Irlanda 110
IN - India 73
KR - Corea 63
TR - Turchia 58
BD - Bangladesh 54
GB - Regno Unito 54
FI - Finlandia 48
AR - Argentina 46
SE - Svezia 46
MX - Messico 42
IL - Israele 41
CA - Canada 37
NL - Olanda 32
JP - Giappone 30
AT - Austria 29
IQ - Iraq 27
EC - Ecuador 24
PL - Polonia 21
ID - Indonesia 19
ZA - Sudafrica 19
PK - Pakistan 17
TN - Tunisia 16
VE - Venezuela 16
CO - Colombia 14
ES - Italia 13
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
PH - Filippine 10
ET - Etiopia 9
MA - Marocco 9
UZ - Uzbekistan 9
PE - Perù 8
DZ - Algeria 7
KE - Kenya 7
BY - Bielorussia 6
CL - Cile 6
CR - Costa Rica 6
OM - Oman 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
EU - Europa 5
JO - Giordania 5
LB - Libano 5
BE - Belgio 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
AZ - Azerbaigian 3
GR - Grecia 3
HN - Honduras 3
KW - Kuwait 3
LT - Lituania 3
SV - El Salvador 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
MD - Moldavia 2
MU - Mauritius 2
PS - Palestinian Territory 2
SN - Senegal 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
Totale 12.121
Città #
Hong Kong 2.896
San Jose 659
Singapore 608
Ann Arbor 567
Dallas 331
Ashburn 317
Woodbridge 317
Chandler 288
Princeton 222
Jacksonville 191
Wilmington 167
Houston 154
Council Bluffs 144
Lauterbourg 114
Dublin 103
The Dalles 101
Ho Chi Minh City 97
Naples 95
Beijing 92
Dong Ket 76
Hanoi 66
Los Angeles 58
Moscow 51
New York 44
Nanjing 41
Santa Clara 41
Izmir 40
Dearborn 39
Andover 35
Boardman 35
Pellezzano 33
São Paulo 31
Salerno 30
Tokyo 28
Washington 27
Amsterdam 23
Mestre 23
Brooklyn 22
Chicago 21
Atlanta 20
Frankfurt am Main 20
Orem 20
Vienna 20
Denver 19
Munich 19
Warsaw 19
Nuremberg 18
Stockholm 18
Düsseldorf 16
San Francisco 16
Shenyang 16
Chennai 15
Seattle 15
London 14
Baghdad 13
Norwalk 13
Pune 13
Rome 13
Da Nang 12
Fairfield 12
Haiphong 12
Johannesburg 12
Montreal 12
Quito 12
Rio de Janeiro 11
Seoul 11
West Jordan 11
Brno 10
Caracas 10
Columbus 10
Hebei 10
Jiaxing 10
Mexico City 10
Phoenix 10
Tianjin 10
Ankara 9
Buenos Aires 9
Curitiba 9
Helsinki 9
Biên Hòa 8
Guayaquil 8
Memphis 8
Nanchang 8
Poplar 8
San Diego 8
Tashkent 8
Addis Ababa 7
Belo Horizonte 7
Charlotte 7
Tunis 7
Boston 6
Brasília 6
Des Moines 6
Florence 6
Jeddah 6
Lappeenranta 6
Manaus 6
Manchester 6
Shanghai 6
Arba 5
Totale 8.908
Nome #
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 741
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 363
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 356
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 338
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 306
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 256
A systematic review of pediatrics NAFLD therapy: year 2012 237
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 233
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 205
Humanization interventions in general pediatric wards: a systematic review 194
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 183
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 180
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 176
Atypical celiac disease presenting as obesity-related liver dysfunction. 170
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 167
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 158
Autoimmune manifestations in pediatric liver transplantation recipients 154
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 151
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 146
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 140
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 137
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 137
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 133
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 133
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 133
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 126
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 124
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 122
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 122
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 120
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 120
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 119
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 118
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 118
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 118
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 118
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 118
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 118
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 118
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 111
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 111
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 107
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 104
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 103
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 101
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 99
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 97
More on vitamin E therapy 96
Global multi-stakeholder endorsement of the MAFLD definition 91
Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024 87
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 87
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 80
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene 78
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 78
Bassa statura non sindromica e ritardo puberale: non solo ritardo costituzionale di crescita e pubertà 75
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 75
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 75
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 74
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 74
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 73
Drug dosing in children with obesity: a narrative updated review 73
Ittero e feci ipocoliche: allarme atresia delle vie biliari 73
Nutrition and Liver Disease 71
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 69
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 69
Real-word experience with Odevixibat in children with Progressive Familial Intrahepatic Cholestasis 67
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 67
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 66
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review 65
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 64
ALAGILLE SYNDROME: IS IT ALWAYS CHOLESTASIS? 63
Genetics, epigenetics and transgenerational transmission of obesity in children 62
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 62
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 62
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 61
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well 59
The gut-liver axis as a target of liver disease management 58
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 57
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 56
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 56
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 54
A persistent fever associated with elevated inflammatory indices and ultrasound lesions of liver and spleen 53
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 53
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase 52
An odd septic arthritis of the hip 52
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 51
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 50
Bronchiolitis: Compliance with guidelines 50
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 49
Diagnosis and management of sclerosing cholangitis and inflammatory bowel disease in children: A survey by SIGENP 49
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 48
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 48
Letter to the Editor in response to: “ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis” 47
An almost accidentally diagnosis 47
Emerging, re‐emerging and/or atypically behaving infectious diseases 46
Thrombotic Features as the Primary Cause of SARS-CoV-2 Related Acute Abdomen in Children 45
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 44
Pregnancy and Metabolic-Associated Fatty Liver Disease 42
The C677T mutation of the 5,1O-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy 42
Isolated aspartate aminotransferase elevation: Is it liver disease or what else? 41
Totale 11.325
Categoria #
all - tutte 40.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 0 87
2021/2022360 5 0 0 3 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024533 29 48 43 25 32 89 41 24 14 43 24 121
2024/20251.193 21 22 19 54 42 190 185 100 184 101 175 100
2025/20267.361 375 1.840 1.514 322 658 282 987 241 329 570 158 85
Totale 12.332